Terns Pharmaceuticals Inc: Navigating Stock Volatility and Strategic Moves in Biopharmaceuticals
Terns Pharmaceuticals Inc’s stock has experienced significant volatility, with a 52-week high of $11.4 USD and a low of $1.865 USD, as the company navigates financial challenges and market expectations in the biopharmaceutical sector.
3 minutes to read